Onsdag 14 Maj | 09:46:13 Europe / Stockholm

Kalender

Est. tid*
2025-12-11 N/A Bokslutskommuniké 2025
2025-08-07 N/A Kvartalsrapport 2025-Q3
2025-05-14 N/A Kvartalsrapport 2025-Q2
2025-03-27 - X-dag ordinarie utdelning AFX 0.60 EUR
2025-03-26 - Årsstämma
2025-02-12 - Kvartalsrapport 2025-Q1
2024-12-11 - Bokslutskommuniké 2024
2024-08-06 - Kvartalsrapport 2024-Q3
2024-05-08 - Kvartalsrapport 2024-Q2
2024-03-22 - X-dag ordinarie utdelning AFX 1.10 EUR
2024-03-21 - Årsstämma
2024-02-09 - Kvartalsrapport 2024-Q1
2023-12-12 - Bokslutskommuniké 2023
2023-08-04 - Kvartalsrapport 2023-Q3
2023-05-09 - Kvartalsrapport 2023-Q2
2023-03-23 - X-dag ordinarie utdelning AFX 1.10 EUR
2023-03-22 - Årsstämma
2023-02-10 - Kvartalsrapport 2023-Q1
2022-12-09 - Bokslutskommuniké 2022
2022-08-05 - Kvartalsrapport 2022-Q3
2022-05-13 - Kvartalsrapport 2022-Q2
2022-03-31 - X-dag ordinarie utdelning AFX 0.90 EUR
2022-03-30 - Årsstämma
2022-02-11 - Kvartalsrapport 2022-Q1
2021-12-10 - Bokslutskommuniké 2021
2021-08-06 - Kvartalsrapport 2021-Q3
2021-05-28 - X-dag ordinarie utdelning AFX 0.50 EUR
2021-05-27 - Årsstämma
2021-05-10 - Kvartalsrapport 2021-Q2
2021-02-08 - Kvartalsrapport 2021-Q1
2020-08-07 - X-dag ordinarie utdelning AFX 0.65 EUR
2020-08-06 - Årsstämma
2020-03-24 - Årsstämma
2019-03-19 - Årsstämma
2024-04-02 12:02:13

EQS Related Party Transactions announcement: Carl Zeiss Meditec AG / Release of an announcement according to Article 111c of the AktG [the German Stock Corporation Act]
Carl Zeiss Meditec AG: Release according to Article 111c of the AktG [the German Stock Corporation Act] with the objective of Europe-wide distribution

02.04.2024 / 12:02 CET/CEST
Dissemination of a Related Party Transactions announcement transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


 

 

 

 

 

 

 
Carl Zeiss Meditec AG enters into a shareholder loan with Carl Zeiss AG to partially finance acquisition of D.O.R.C.
 
Jena, April 2, 2024
Carl Zeiss Meditec AG (ISIN: DE0005313704) entered into a loan agreement with Carl Zeiss AG, Oberkochen, Germany on April 2, 2024. Carl Zeiss AG directly and indirectly holds around 59% of shares in Carl Zeiss Meditec AG. Purpose of the loan is to partially finance the acquisition of Dutch Ophthalmic Research Center (International) BV, Zuidland, Netherlands (D.O.R.C.), as announced on Dec 15, 2023.
Under this loan agreement, Carl Zeiss Meditec AG receives an unsecured loan from Carl Zeiss AG in the amount of €400 million at an interest rate of 3.66% p.a., due in full no later than 3 years starting from the disbursement. The loan can be repaid in part or in full at any time ahead of the maturity date.
The Supervisory Board of Carl Zeiss Meditec AG has approved the conclusion of the loan agreement.
 

Contact for investors and press

Sebastian Frericks

Head of Group Finance & Investor Relations

Carl Zeiss Meditec AG

Address: Goeschwitzer Straße 51-52, 07745 Jena, Germany

Tel.: +49 3641 220-116

E-Mail: investors.meditec@zeiss.com

 

 

 

 

 

 

 

 

 



02.04.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Carl Zeiss Meditec AG
Göschwitzer Str. 51-52
07745 Jena, Germany
Germany
Internet: www.zeiss.de/meditec-ag/ir

 
End of News EQS News Service

1871475  02.04.2024 CET/CEST